Jiangsu Nhwa Pharmaceutical Co., Ltd. Jiangsu Nhwa Pharmaceutical Co., Ltd.

Jiangsu Nhwa Pharmaceutical Co., Ltd.

002262

Classifica tra le azioni #4721
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
Prezzo delle azioni
$3.15
Capitalizzazione di mercato
$3.19B
Variazione (1 giorno)
-0.05%
Variazione (1 anno)
-12.63%
Paese
CN
Scambia Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)

Categoria

Healthcare
EPS per Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
EPS al June 2026 TTM: $0.16
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Jiangsu Nhwa Pharmaceutical Co., Ltd., l’EPS attuale della società (TTM) è $0.16. Alla fine del 2023, la società aveva un EPS di $0.15 un aumento rispetto a rispetto a quello del 2022, che era di $0.13.
Storico EPS per Jiangsu Nhwa Pharmaceutical Co., Ltd. da 2005 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) $0.16 4.33%
2024 $0.15 6.39%
2023 $0.15 12.79%
2022 $0.13 3.78%
2021 $0.12 12.79%
2020 $0.11 17.11%
2019 $0.09 24.47%
2018 $0.08 26.21%
2017 $0.06 34.30%
2016 $0.04 11.50%
2015 $0.04 8.99%
2014 $0.04 23.57%
2013 $0.03 30.26%
2012 $0.02 20.00%
2011 $0.02 43.94%
2010 $0.01 43.48%
2009 $0.01 15.00%
2008 $0.01 42.86%
2007 $0.01 19.15%
2006 0.00 -16.07%
2005 $0.01 0.00%
EPS per aziende simili o concorrenti